Midgard Science
R

RudaCure

Incheon, South Korea rudacure.com From their website, Nov 2026

Work here? Claim this listing

About

RudaCure is a Korean drug discovery company focused on membrane proteins, including ion channels and GPCRs, to develop therapeutics for dry eye disease, chronic pain, psoriasis and rare neurological disease. It also provides CRO services related to pharmacology evaluation, in vivo and in vitro assessment, ion-channel screening and ocular-disease animal models. The company is based in Incheon with a Seoul office.

Services

  • Pharmacology evaluation

    Evaluates drug candidates using pharmacology methods as part of CRO services.

  • In vivo assessment

    Conducts in vivo assessment services for drug discovery programs.

  • In vitro assessment

    Conducts in vitro assessment services for drug discovery programs.

  • Ion-channel screening

    Screens compounds for ion-channel activity and selectivity.

  • Ocular-disease animal models

    Uses animal models for ocular-disease research and evaluation.

Capabilities

Assays and studies
  • Patch clamp
  • AAV
  • In vivo
  • Electrophysiology
  • High-throughput electrophysiology
  • Pharmacology evaluation
4 more
  • AI-based molecular prediction
  • Structure-based design
  • Molecular dynamics simulations
  • Ion-channel screening
Scale and capacity
6 sites
Therapeutic areas
  • Dry eye disease
  • Chronic pain
  • Psoriasis
  • Rare neurological disease
  • Pain
  • Ophthalmology
5 more
  • Dermatology
  • Veterinary
  • Sensory disease
  • Inflammatory disease
  • Veterinary dry eye

Instruments and platforms

  • Patch clamp

Modalities and species

Modalities
Viral vector
Species and models
  • Ocular-disease animal models
  • TRPV1
  • GPCR
  • Ion channels
  • Dry eye disease model
  • Sjögren's syndrome model

Industries served

  • Biotech
  • Veterinary pharma

Company

Type
CRO
Founded
2018

Locations

Based in
Incheon, South Korea
Sites
Seoul, Korea
Serves
Korea, US, Japan, Europe

Contacts

Similar labs